These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33747044)
1. Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer. Qian Y; Wei J; Lu W; Sun F; Hwang M; Jiang K; Fu D; Zhou X; Kong X; Zhu Y; Xiao Q; Hu Y; Ding K Front Genet; 2021; 12():619611. PubMed ID: 33747044 [TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
3. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. Wang S; Cheng L; Jing F; Li G BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
5. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
6. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
7. A novel prognostic signature of immune-related genes for patients with colorectal cancer. Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer. Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L Front Genet; 2021; 12():666003. PubMed ID: 34017356 [TBL] [Abstract][Full Text] [Related]
9. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors. Yang S; Wu Y; Deng Y; Zhou L; Yang P; Zheng Y; Zhang D; Zhai Z; Li N; Hao Q; Song D; Kang H; Dai Z Oncoimmunology; 2019; 8(12):e1659094. PubMed ID: 31741756 [TBL] [Abstract][Full Text] [Related]
10. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer. Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q Front Genet; 2022; 13():851373. PubMed ID: 35401707 [No Abstract] [Full Text] [Related]
11. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer. Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182 [TBL] [Abstract][Full Text] [Related]
12. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
13. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer. Lin K; Huang J; Luo H; Luo C; Zhu X; Bu F; Xiao H; Xiao L; Zhu Z Aging (Albany NY); 2020 Mar; 12(7):5832-5857. PubMed ID: 32235004 [TBL] [Abstract][Full Text] [Related]
14. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer. Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664 [TBL] [Abstract][Full Text] [Related]
15. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. Qi X; Qi C; Qin B; Kang X; Hu Y; Han W Front Oncol; 2020; 10():541330. PubMed ID: 33072571 [No Abstract] [Full Text] [Related]
16. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
17. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer. Ma XB; Xu YY; Zhu MX; Wang L Front Oncol; 2020; 10():591739. PubMed ID: 33680920 [TBL] [Abstract][Full Text] [Related]
18. Establishment of an immune-related gene prognostic model for head and neck tumors. Zhou F; Chen AX; Lv HY; Liang DH; Yu HS J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769 [TBL] [Abstract][Full Text] [Related]
19. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer. Du H; Pang S; Li Y; Zhu L; Hang J; Chen L J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327 [TBL] [Abstract][Full Text] [Related]
20. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma. Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188 [No Abstract] [Full Text] [Related] [Next] [New Search]